CompuGroup Medical AG Second Quarter Results 2015

CompuGroup Medical AGCompuGroup Medical AG today presented the financial report for the second quarter of 2015. The company, one of the leading global providers of eHealth solutions, achieved revenue of EUR 138 million, compared to EUR 126 million in the second quarter 2014. This represents an increase of 9 percent, of which 4 percent is organic growth.

With this result, the good start to the year continues for CompuGroup Medical. There is broad-based progress in most business areas and a pronounced group-wide margin increase as the most notable improvement. Consolidated EBITDA in the second quarter amounted to EUR 30 million compared to EUR 23 million in 2014. The corresponding operating margin was well above 21 percent compared to 18 percent in 2014.

The hospital segment has developed particularly well in the period and it is the market in Poland that contributes with a high organic growth rate driven by a larger CGM participation in the on-going national e-health project there. Order intake has also improved in the hospital area and CGM was in June awarded the contract for the implementation and delivery of a comprehensive new hospital information system for five regional hospitals in Vorarlberg, Austria.

Parallel to the positive financial and operational development, CGM continues its prominent role in the largest on-going eHealth initiative in Germany - the Telematics Infrastructure and Electronic Health Card (eGK) pilot project. At the Hauptstadtkongress in Berlin in June, CGM showed live for the second time the insured master data update based on the eGK. With an official real-life demonstration of all required hardware and software components fully functional, CGM shows its readiness for a successful rollout to test the Telematics Infrastructure in in the pilot region North/West.

Frank Gotthardt, CEO and Chairman of the Board of CompuGroup Medical AG, stated: "The numbers we deliver for the second quarter reaffirm our commitment to improve margins and profitability for the Group. While doing this, we also drive the electronic health card project in Germany forward with full commitment. A worthy finish to the quarter came with the our new hospital contract in Austria which shows the increasing leverage we are getting in the market from our long-time investment in our next generation G3 product platform."

CompuGroup Medical reaffirms the full year 2015 guidance presented in the 2014 Annual Report. Including revenue from recent acquisitions, Group revenue is expected to be in the range of EUR 549 million to EUR 559 million and operating income (EBITDA) is expected to be in the range of EUR 115 million to EUR 125 million.

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of more than EUR 500 million, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of approximately 400,000 doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 19 countries and products in more than 40 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 4,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...